Results 201 to 210 of about 1,673,984 (332)

Patient and public perspectives on the availability of their health and advance care planning information to support care at the end of life: a mixed-methods questionnaire study. [PDF]

BMJ Open
Birtwistle J, Russell AM, Relton SD, Easdown H, Grieve U, Allsop M.   +5 more
europepmc   +1 more source

Screening for lung cancer: A systematic review of overdiagnosis and its implications

Molecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz, Laura de la Torre‐Perez, David R Baldwin, Carlijn van der Aalst, Mangesh Thorat, David Ritchie, Andre L Carvalho, Carolina Espina, Ivan Solà, Carlos Canelo‐Aybar, Moira Magdalena Pissinis, Pablo Alonso‐Coello, Ana Carolina Pereira Nunes Pinto   +12 more
wiley   +1 more source

Prognostic Factors in the Treatment of Advanced Endometrial Cancer Patients: 12-Year Experience of an ESGO Certified Center. [PDF]

Cancers (Basel)
Zouzoulas D, Sofianou I, Markopoulou E, Karalis T, Chatzistamatiou K, Theodoulidis V, Topalidou M, Timotheadou E, Grimbizis G, Tsolakidis D.   +9 more
europepmc   +1 more source

Recommendations for advancing the care of Canadians living with refractory angina pectoris: A Canadian Cardiovascular Society position statement

, 2009
Michael McGillion, Philippe L. L’Allier, Heather M. Arthur, Judy Watt‐Watson, Nelson Svorkdal, Tammy Cosman, Paul Taenzer, Anil Nigam, Louise Malysh   +8 more
openalex   +2 more sources

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Evaluation of early experiences of the Mental Health (Care & Treatment) (Scotland) Act 2003: A cohort study [PDF]

, 2009
Cummings, Lea, Edkins, Vincent, Fallan, Francis, Hunter, Susan, Laird, Tracy, Little, Simon, McLaughlin, Anne, Muir, Jen, Ridley, Julie, Rosengard, Ann, Thomson, Agnes, Whitelaw, Janette   +11 more
core  

Survivin and Aurora Kinase A control cell fate decisions during mitosis

Molecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir, Shalitha Wickrama Arachchige, Sally P. Wheatley   +2 more
wiley   +1 more source

Seeking consensus on dilemmas related to euthanasia in dementia based on an advance directive: a Delphi study from a medical, ethical and legal perspective. [PDF]

J Med Ethics
de Boer ME, Coers DO, Sizoo EM, Ten Bokkel Huinink DMJ, Leget CJW, Hertogh CMPM, DALT project group.   +6 more
europepmc   +1 more source

FORMATION OF PUBLICITY [PDF]

, 2013
Bagrova, I.V., Lyaskovskaya, A.
core  

Use of the International Pharmaceutical Federation’s Basel Statements to Assess and Advance Hospital Pharmacy Practice: A Scoping Review

, 2016
Jonathan Penm, Betty Chaar, Rebekah Moles   +2 more
openalex   +2 more sources